首页 | 本学科首页   官方微博 | 高级检索  
检索        

布地耐德异丙托溴铵联合雾化吸入治疗慢性阻塞性肺疾病急性发作期的临床试验
引用本文:刘涛,刘莉莎.布地耐德异丙托溴铵联合雾化吸入治疗慢性阻塞性肺疾病急性发作期的临床试验[J].黑龙江医学,2009,33(2).
作者姓名:刘涛  刘莉莎
作者单位:黑龙江省医院南岗分院呼吸内科,黑龙江,哈尔滨,150001
摘    要:目的评价布地耐德异丙托溴铵联合雾化吸入对慢性阻塞性肺疾病急性发作期的治疗。方法2例慢性阻塞性肺疾病急性发作期的患者临床试验,分为治疗组和对照组。治疗组是在一般治疗的基础上加用布地耐德异丙拖溴铵联合雾化吸入治疗10 d;治疗组和对照组均在用药前后对呼吸困难评分、肺功能检查、空腹血糖测定及不良反应评价,并进行对比。结果治疗组较对照组患者的呼吸困难症状、FEV1有明显改善。结论吸入布地耐德异丙托溴铵联合雾化,具有起效快、不良反应少等优点,减少复发的次数,缓解患者的病情。

关 键 词:布地耐德  异丙托溴铵  联合雾化吸入  慢性阻塞性肺疾病

Clinical Test on Combined Atomization of Budenide and Ipratropium Bromide for COPD in Acute Episode Stage
LIU Tao,LIU Li-sha.Clinical Test on Combined Atomization of Budenide and Ipratropium Bromide for COPD in Acute Episode Stage[J].Heilongjiang Medical Journal,2009,33(2).
Authors:LIU Tao  LIU Li-sha
Institution:LIU Tao,LIU Li-sha(Department of Respiratory,The Nangang Branch Hospital of Heilongjiang Privince,Harbin 150001,China)
Abstract:Objective To assess the curative effect of COPD in acute episode stage treated with Budenide and ipratropium bromide.Methods 2 cases of such patient were divided into two groups;therapy group and control group.The therapy group was treated with budenide on the bases of ipratropium bromide atomization for 10 days.the dyspnea,lung function,blood glucose and side effect of both groups were compared.Results The situation of respiratory and FEV1 were improved in therapy group than those of control group.Conclusi...
Keywords:Budenide  Ipratropium bromide  Atomization of combination  COPD  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号